Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms.

Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms. Abstract Text:

Background: Implantable cardioverter defibrillator (ICD) implant testing based on the upper limit of vulnerability, or vulnerability testing, permits assessment of defibrillation safety margins without inducing ventricular fibrillation (VF) in most patients. Vulnerability testing requires that T-wave shocks be timed at the most vulnerable intervals of the cardiac cycle, defined as intervals at which the strongest shock induces VF. Our goal was to develop and test an automated method to select these timing intervals using ICD intracardiac electrograms (EGMs). Methods: At ICD implant in 22 patients, we determined the range of the most vulnerable intervals by scanning the T wave with shocks. Simultaneously, EGMs were recorded for 351 pacing sequences used for measurement of timing intervals or T-wave shocks. EGMs were analyzed off-line using a novel automated method to identify a stable point near the maximum slope of the T wave in the far-field (shock) EGM. Fiducial timing points based both on the EGM and on the electrocardiogram (ECG) were used to predict the most vulnerable intervals. We compared the predicted most vulnerable to the measured most vulnerable intervals determined by T-shock scans. Results: Automatically determined timing points from EGMs and operator-determined timing points from the surface ECG had comparable accuracy in identifying the measured most vulnerable intervals (91% EGM vs 86% ECG, P = NS). Conclusions: An automated method based on ICD EGMs identifies the most vulnerable intervals with accuracy comparable to the operator-performed, clinical method based on the surface ECG. This EGM method can be implemented efficiently in an ICD to automate vulnerability testing.

Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Pacing and clinical electrophysiology : PACE

VOLUME: 31

Page Numbers: 691-700

Journal Abbreviation:

ISSN: 1540-8159

DAY: 29

MONTH: Jun

YEAR: 2008

Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7803944

Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms.

AFFILIATION: Division of Cardiology, Cedars-Sinai Medical Center and the David Geffen School of Medicine UCLA, Los Angeles, California, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pacing Clin Electrophysiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms Related Publications

• Atypical cellular disorders.
• Automatic Determination of Timing Intervals for Upper Limit of Vulnerability Using ICD Electrograms.
• Bowel perforation following enema through a permanent colostomy.
• Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
• Characterization of alkali soaps by electron microscopy.
• Complex I deficiency in Parkinson's disease frontal cortex.
• Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens.
• Effects of memantine on mitochondrial function.
• Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders.
• Idiosyncrasy to thiopentone.
• Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine.
• Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
• Lethal effect of triethylene glycol vapor on air-borne mumps virus and Newcastle disease virus.
• MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia.
• Management of chronic pain.
• Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies.
• Nodal aggressive B-cell lymphomas: a diagnostic approach.
• Ocular motor responses to unpredictable and predictable smooth pursuit stimuli among patients with obsessive-compulsive disorder.
• Pathogenesis of Alzheimer's disease.
• Prophylaxis after Exposure to Coxiella burnetii.
• Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses.
• Recommendations for the reporting of lymphoid neoplasms: A report from the Association of Directors of Anatomic and Surgical Pathology.
• Red cell exchange in sickle cell disease.
• Sex ratio in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan.
• Short-term effect of dementia disclosure: how patients and families describe the diagnosis.
• Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.
• The effects of apomorphine and D-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny.
• The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells.
• Thiopentone-curare in abdominal surgery.
• Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem.